References
- Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther 2004;17:212-8. https://doi.org/10.1111/j.1396-0296.2004.04022.x
- Kelly AP. Keloids. Dermatol Clin 1988;6:413-24.
- Child FJ, Fuller LC, Higgins EM, et al. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol 1999;141:512-7. https://doi.org/10.1046/j.1365-2133.1999.03047.x
- Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002;46:S63-97. https://doi.org/10.1067/mjd.2002.120788
- Marneros AG, Norris JE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol 2001;137:1429-34. https://doi.org/10.1001/archderm.137.11.1429
- LeFlore IC. Misconceptions regarding elective plastic surgery in the black patient. J Natl Med Assoc 1980;72:947-8.
- Alhady SM, Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 1969;44:564-6. https://doi.org/10.1097/00006534-196912000-00006
- Bayat A, Arscott G, Ollier WE, et al. "Aggressive keloid": a severe variant of familial keloid scarring. J R Soc Med 2003; 96:554-5. https://doi.org/10.1258/jrsm.96.11.554
- Marneros AG, Norris JE, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004;122:1126-32. https://doi.org/10.1111/j.0022-202X.2004.22327.x
- Chen Y, Gao JH, Liu XJ, et al. Characteristics of occurrence for Han Chinese familial keloids. Burns 2006;32:1052-9. https://doi.org/10.1016/j.burns.2006.04.014
- Bella H, Heise M, Yagi KI, et al. A clinical characterization of familial keloid disease in unique African tribes reveals distinct keloid phenotypes. Plast Reconstr Surg 2011;127:689-702. https://doi.org/10.1097/PRS.0b013e3181fed645
- Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 1974;53:276-80. https://doi.org/10.1097/00006534-197403000-00004
- Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975;67:428-32.
- Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res 2010;302:319-39. https://doi.org/10.1007/s00403-009-1014-y
- Stevens CA, Pouncey J, Knowles D. Adults with Rubinstein- Taybi syndrome. Am J Med Genet A 2011;155A:1680-4.
- Siraganian PA, Rubinstein JH, Miller RW. Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 1989;17:485-91.
- Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995;376:348-51. https://doi.org/10.1038/376348a0
- Nadeau A, Kinali M, Main M, et al. Natural history of Ullrich congenital muscular dystrophy. Neurology 2009;73:25-31. https://doi.org/10.1212/WNL.0b013e3181aae851
- Goeminne L. A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids cryptorchidism and renal dysplasia. Acta Genet Med Gemellol (Roma) 1968;17:439-67. https://doi.org/10.1017/S1120962300012634
- Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 2012;26:141-52. https://doi.org/10.1111/j.1468-3083.2011.04200.x
- Chalmers RL. The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring. Int Wound J 2011;8:218-23. https://doi.org/10.1111/j.1742-481X.2011.00771.x
- Murata H, Zhou L, Ochoa S, et al. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J Invest Dermatol 1997;108: 258-62. https://doi.org/10.1111/1523-1747.ep12286451
- Thompson SA, Canady JW, Coberly DM, et al. Effects of TGFbeta2 on collagen synthesis in cultured normal and wounded fetal mouse palates. Cleft Palate Craniofac J 1999; 36:425-33. https://doi.org/10.1597/1545-1569(1999)036<0425:EOTOCS>2.3.CO;2
- Bettinger DA, Yager DR, Diegelmann RF, et al. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996;98:827-33. https://doi.org/10.1097/00006534-199610000-00012
- Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991;97:240-8. https://doi.org/10.1111/1523-1747.ep12480289
- Messadi DV, Le A, Berg S, et al. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 1998;3:a16-22. https://doi.org/10.2741/A246
- Fujiwara M, Muragaki Y, Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005;297:161-9. https://doi.org/10.1007/s00403-005-0596-2
- Gao Z, Wang Z, Shi Y, et al. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA. Plast Reconstr Surg 2006;118:1328-37. https://doi.org/10.1097/01.prs.0000239537.77870.2c
- Wang Z, Gao Z, Shi Y, et al. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007;60:1193-9. https://doi.org/10.1016/j.bjps.2006.05.007
- Chen Y, Gao JH, Liu XJ, et al. Linkage analysis of keloid susceptibility loci on chromosome 7p11 in a Chinese pedigree. Nan Fang Yi Ke Da Xue Xue Bao 2006;26:623-5.
- Yan X, Gao JH, Chen Y, et al. Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23: 32-5.
- Chen Y, Gao JH, Yan X, et al. Location of predisposing gene for one Han Chinese keloid pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23:137-40.
- Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002;55:283-6. https://doi.org/10.1054/bjps.2002.3853
- Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003;111:535-43. https://doi.org/10.1097/01.PRS.0000041536.02524.A3
- Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 2004;13:120-4. https://doi.org/10.1111/j.0906-6705.2004.00165.x
- Bayat A, Walter JM, Bock O, et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 2005;58:914-21. https://doi.org/10.1016/j.bjps.2005.04.009
- Lu WS, Zhang WY, Li Y, et al. Association of HLA-DRB1 alleles with keloids in Chinese Han individuals. Tissue Antigens 2010;76:276-81. https://doi.org/10.1111/j.1399-0039.2010.01509.x
- Zhang G, Jiang J, Luo S, et al. Analyses of CDC2L1 gene mutations in keloid tissue. Clin Exp Dermatol 2012;37:277-83. https://doi.org/10.1111/j.1365-2230.2011.04225.x
- Brown JJ, Ollier WE, Thomson W, et al. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 2008;35:303-7. https://doi.org/10.1111/j.1744-313X.2008.00780.x
- Yan L, Lu XY, Wang CM, et al. Association between p53 gene codon 72 polymorphism and keloid in Chinese population. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23:428-30.
- Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8:93-7. https://doi.org/10.1093/hmg/8.1.93
- Brown JJ, Ollier W, Arscott G, et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro- Caribbeans. Exp Dermatol 2008;17:610-3. https://doi.org/10.1111/j.1600-0625.2007.00654.x
- Shih B, Bayat A. Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res. 2012;304:241-9. https://doi.org/10.1007/s00403-011-1182-4
- Nakashima M, Chung S, Takahashi A, et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 2010;42:768-71. https://doi.org/10.1038/ng.645
- Chung S, Nakashima M, Zembutsu H, et al. Possible involvement of NEDD4 in keloid formation; its critical role in fibro blast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:563-73. https://doi.org/10.2183/pjab.87.563
- Russell SB, Russell JD, Trupin KM, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010;130:2489-96. https://doi.org/10.1038/jid.2010.162
Cited by
- Intralesional Treatment for Keloids and Hypertrophic Scars: A Review vol.39, pp.12, 2013, https://doi.org/10.1111/dsu.12346
- Models of Abnormal Scarring vol.2013, pp.None, 2012, https://doi.org/10.1155/2013/423147
- Photodynamic therapy: an innovative approach to the treatment of keloid disease evaluated using subjective and objective non-invasive tools vol.305, pp.3, 2012, https://doi.org/10.1007/s00403-012-1295-4
- Cochlear implant extrusion secondary to keloid formation vol.15, pp.5, 2012, https://doi.org/10.1179/1754762814y.0000000078
- Wound healing: an update vol.9, pp.6, 2012, https://doi.org/10.2217/rme.14.54
- Synergistic Effect of Interleukin-6 and Hyaluronic Acid on Cell Migration and ERK Activation in Human Keratinocytes vol.29, pp.suppl3, 2012, https://doi.org/10.3346/jkms.2014.29.s3.s210
- Inhibition of Hyaluronan Synthase 2 Reduces the Abnormal Migration Rate of Keloid Keratinocytes vol.35, pp.1, 2014, https://doi.org/10.1097/bcr.0b013e3182a2a9dd
- Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation vol.306, pp.4, 2014, https://doi.org/10.1007/s00403-014-1438-x
- Hypertrophe Narben und Keloide vol.7, pp.2, 2015, https://doi.org/10.1007/s12634-015-0837-0
- New approach to the understanding of keloid: psychoneuroimmune–endocrine aspects vol.8, pp.None, 2012, https://doi.org/10.2147/ccid.s49195
- Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds vol.53, pp.3, 2012, https://doi.org/10.3109/13880209.2014.918157
- High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars vol.3, pp.6, 2012, https://doi.org/10.1097/gox.0000000000000391
- LncRNA expression profiles and validation in keloid and normal skin tissue vol.47, pp.5, 2012, https://doi.org/10.3892/ijo.2015.3177
- Pleiotrophin is downregulated in human keloids vol.308, pp.8, 2012, https://doi.org/10.1007/s00403-016-1678-z
- Cutaneous basal cell carcinoma arising within a keloid scar: a case report vol.9, pp.None, 2012, https://doi.org/10.2147/ott.s113724
- The molecular basis of hypertrophic scars vol.4, pp.1, 2012, https://doi.org/10.1186/s41038-015-0026-4
- Epidermal Growth Factor (EGF)-Like Repeats and Discoidin I-Like Domains 3 (EDIL3): A Potential New Therapeutic Tool for the Treatment of Keloid Scars vol.14, pp.3, 2012, https://doi.org/10.1007/s13770-017-0034-5
- Upregulation of microRNA-205 suppresses vascular endothelial growth factor expression-mediated PI3K/Akt signaling transduction in human keloid fibroblasts vol.242, pp.3, 2012, https://doi.org/10.1177/1535370216669839
- DNA methylation of the CDC2L1 gene promoter region decreases the expression of the CDK11p58 protein and reduces apoptosis in keloid fibroblasts vol.310, pp.2, 2012, https://doi.org/10.1007/s00403-017-1801-9
- Coherency image analysis to quantify collagen architecture: implications in scar assessment vol.8, pp.18, 2018, https://doi.org/10.1039/c7ra12693j
- Complete excision of proliferating core in auricular keloids significantly reduces local recurrence: A prospective study vol.45, pp.2, 2012, https://doi.org/10.1111/1346-8138.14110
- miR-34 modulates apoptotic gene expression in Ingenol mebutate treated keloid fibroblasts vol.17, pp.5, 2012, https://doi.org/10.3892/mmr.2018.8749
- Successful Spine-Shortening Osteotomy for Recurrent Tethered Cord Syndrome in a Patient with Ehlers-Danlos Type III and Mosaic Trisomy 20: A Case Report vol.5, pp.1, 2012, https://doi.org/10.5812/soj.64977
- Gene‐based evaluation of low‐frequency variation and genetically‐predicted gene expression impacting risk of keloid formation vol.82, pp.4, 2012, https://doi.org/10.1111/ahg.12245
- Identification and integrated analysis of microRNA expression profiles in keloid vol.17, pp.5, 2018, https://doi.org/10.1111/jocd.12706
- Toward understanding scarless skin wound healing and pathological scarring vol.8, pp.None, 2012, https://doi.org/10.12688/f1000research.18293.1
- Wound Healing: A Cellular Perspective vol.99, pp.1, 2012, https://doi.org/10.1152/physrev.00067.2017
- A Novel Radiotherapy Approach for Keloids with Intrabeam vol.2019, pp.None, 2012, https://doi.org/10.1155/2019/4693528
- Keloid research: current status and future directions vol.5, pp.None, 2012, https://doi.org/10.1177/2059513119868659
- Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/6179063
- Comparison of the efficacy of intralesional bleomycin versus intralesional triamcinolone acetonide in the treatment of keloids vol.32, pp.5, 2019, https://doi.org/10.1111/dth.13036
- Imiquimod to prevent keloid recurrence postexcision: A systematic review and meta‐analysis vol.28, pp.1, 2012, https://doi.org/10.1111/wrr.12766
- Neuronal Precursor Cell Expressed Developmentally Down Regulated 4 (NEDD4) Gene Polymorphism Contributes to Keloid Development in Egyptian Population vol.13, pp.None, 2012, https://doi.org/10.2147/ccid.s253603
- Long non-coding RNA HOXA11-AS accelerates the progression of keloid formation via miR-124-3p/TGFβR1 axis vol.19, pp.2, 2012, https://doi.org/10.1080/15384101.2019.1706921
- Animal models of scarring control vol.34, pp.2, 2020, https://doi.org/10.1038/s41433-019-0727-1
- Replication study of four keloid-associated polymorphisms in patients of European descent - a single centre study vol.9, pp.1, 2012, https://doi.org/10.5582/irdr.2020.01013
- Laser fluorescence spectroscopy in predicting the formation of a keloid scar: preliminary results and the role of lipopigments vol.11, pp.4, 2012, https://doi.org/10.1364/boe.386029
- Identification of Differentially Methylated CpG Sites in Fibroblasts from Keloid Scars vol.8, pp.7, 2012, https://doi.org/10.3390/biomedicines8070181
- Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions vol.31, pp.5, 2012, https://doi.org/10.1080/09546634.2019.1628171
- Hypoxia and HIF-1α Regulate Collagen Production in Keloids vol.140, pp.11, 2012, https://doi.org/10.1016/j.jid.2020.01.036
- Efficacy and Safety of Botulinum Toxin Type A in Preventing Postoperative Scars and Improving the Cosmetic Appearance of Scars: A Systematic Review and Meta-Analysis vol.24, pp.6, 2012, https://doi.org/10.1177/1203475420937963
- Current Advances in Hypertrophic Scar and Keloid Management vol.35, pp.3, 2012, https://doi.org/10.1055/s-0041-1731461
- Update on management of keloid and hypertrophic scars: A systemic review vol.20, pp.9, 2012, https://doi.org/10.1111/jocd.14310
- Risk of cancer development in patients with keloids vol.11, pp.1, 2012, https://doi.org/10.1038/s41598-021-88789-1
- Effectiveness of combined microfocused ultrasound with visualization and subdermal calcium hydroxyapatite injections for the management of brachial skin laxity vol.20, pp.12, 2021, https://doi.org/10.1111/jocd.14573
- The association between keloid and osteoporosis: real-world evidence vol.22, pp.1, 2012, https://doi.org/10.1186/s12891-020-03898-8
- Efficacy and safety of botulinum toxin type A for postoperative scar prevention and wound healing improvement: A systematic review and meta‐analysis vol.21, pp.1, 2022, https://doi.org/10.1111/jocd.14617